دورية أكاديمية

Robotic Partial Cystectomy for Primary Urachal Adenocarcinoma of the Urinary Bladder.

التفاصيل البيبلوغرافية
العنوان: Robotic Partial Cystectomy for Primary Urachal Adenocarcinoma of the Urinary Bladder.
المؤلفون: James K; Hertfordshire and Bedfordshire Robotic Urological Cancer Centre, Department of Urology, Stevenage, Hatfield, UK., Vasdev N; Hertfordshire and Bedfordshire Robotic Urological Cancer Centre, Department of Urology, Stevenage, Hatfield, UK.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK., Mohan-S G; Department of Anaesthetics; Lister Hospital, Stevenage, Hatfield, UK., Lane T; Hertfordshire and Bedfordshire Robotic Urological Cancer Centre, Department of Urology, Stevenage, Hatfield, UK., Adshead JM; Hertfordshire and Bedfordshire Robotic Urological Cancer Centre, Department of Urology, Stevenage, Hatfield, UK.
المصدر: Current urology [Curr Urol] 2015 Dec; Vol. 8 (4), pp. 183-188. Date of Electronic Publication: 2015 Nov 10.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101471188 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1661-7649 (Print) Linking ISSN: 16617649 NLM ISO Abbreviation: Curr Urol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2021- : [Hagerstown, MD] : Wolters Kluwer Health, Inc.
Original Publication: Basel, Switzerland : Karger, c2007-
مستخلص: We present the largest reported consecutive series on robotic partial cystectomy in the management of patients with primary urachal adenocarcinoma. Eight patients with primary urachal adenocarcinoma of the urinary bladder underwent a robotic partial cystectomy. The mean operative time, including trocar placement as well as robotic docking and closure was 184 minutes (range 130-240 minutes). The mean console time was 120 minutes (range 70-170 minutes). The mean estimated blood loss was 50 ml. There were no conversions to open surgery. The mean hospital stay was 4 days (range 3-7 days). Drain removal was performed at postoperative day 2.5 (range 2-3 days). Each patient underwent postoperative cystography on day 10 postoperatively and no patients had evidence of extravasation. There were no major complications. Histological analysis of all tumors confirmed primary urachal adenocarcinoma of the urinary bladder. There were no positive surgical margins. At a mean follow up of 32 months none of the patients have had a disease recurrence with any evidence of disease recurrence. Our initial data indicates that with robotic partial cystectomy for primary urachal adenocarcinoma of the urinary bladder is a safe surgical and oncological procedure. However, longer follow up and larger patient numbers are required to validate this further.
References: J Urol. 2012 Oct;188(4):1115-9. (PMID: 22901583)
Ecancermedicalscience. 2013 Sep 26;7:354. (PMID: 24101943)
Urology. 1993 Dec;42(6):635-9. (PMID: 8256396)
Int J Urol. 2007 Oct;14(10):963-5. (PMID: 17880303)
Curr Opin Urol. 2001 May;11(3):309-20. (PMID: 11371786)
Semin Oncol. 2012 Oct;39(5):619-24. (PMID: 23040259)
J Urol. 2007 Jul;178(1):74-8; discussion 78. (PMID: 17499279)
Urology. 2006 Feb;67(2):423.e15-423.e17. (PMID: 16461107)
Br J Urol. 1998 Aug;82(2):206-12. (PMID: 9722755)
Korean J Urol. 2010 May;51(5):318-22. (PMID: 20495694)
Br J Urol. 1971 Aug;43(4):468-76. (PMID: 5095577)
Arch Esp Urol. 2013 Jul-Aug;66(6):608-13. (PMID: 23985464)
Int Braz J Urol. 2009 Sep-Oct;35(5):609. (PMID: 19860941)
Urology. 2002 Jul;60(1):39-45; discussion 45. (PMID: 12100918)
Eur Urol. 2010 Feb;57(2):274-81. (PMID: 19560255)
Urology. 1997 Apr;49(4):536-40. (PMID: 9111622)
J Endourol. 2010 Feb;24(2):223-7. (PMID: 20039797)
World J Urol. 2006 Aug;24(3):296-304. (PMID: 16518661)
Urology. 1983 Apr;21(4):357-9. (PMID: 6836821)
Eur Urol. 2003 Feb;43(2):106-12. (PMID: 12565766)
Cancer. 2006 Aug 15;107(4):712-20. (PMID: 16826585)
فهرسة مساهمة: Keywords: Adenocarcinoma; Bladder cancer; Partial cystectomy
تواريخ الأحداث: Date Created: 20180929 Latest Revision: 20210612
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6151324
DOI: 10.1159/000365714
PMID: 30263024
قاعدة البيانات: MEDLINE
الوصف
تدمد:1661-7649
DOI:10.1159/000365714